Kim Kardashian’s Instagram praise for Duchesnay USA’s Diclegis drew a rebuke from the FDA Office of Prescription Drug Promotion for overemphasizing efficacy relative to the drug’s risks and approved indications.

from Forbes – Tech http://ift.tt/1gxsHAD
via IFTTT